Just answered my own question as above. It was mentioned in the April 2024 Qtrly that the study would be performed at UNSW using the Walter Reed methodology. Also mentioned that both biomarker and MRI would be done to assess TBI results, but that UNSW would only do the MRI study. So the biomarker results are still awaited from another research facility. One might have thought that the announcement yesterday might have added a comment on the progress of the biomarker work ( assuming it is underway).
Ann: Significant Neuroprotection in Traumatic Brain Injury Study, page-22
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
23.5¢ |
Change
0.035(17.5%) |
Mkt cap ! $49.56M | |||
| Open | High | Low | Value | Volume |
| 20.0¢ | 23.5¢ | 20.0¢ | $405.2K | 1.907M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 31257 | 23.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 24.0¢ | 103993 | 4 |
View Market Depth
| Last trade - 16.10pm 17/06/2025 (20 minute delay) ? |
| NYR (ASX) Chart |